Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03093597
Other study ID # 1701110479
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 27, 2017
Est. completion date December 12, 2017

Study information

Verified date January 2017
Source University of Arizona
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to compare the changes in the appearance of dry skin after the use various moisturizers: white petrolatum ointment, coconut oil, jojoba oil, and almond oil in patients with dry skin.


Description:

The goal of this study is to compare how the appearance of dry skin changes before and after the use of following moisturizers: white petrolatum, coconut oil, jojoba oil and almond oil). Up to 40 subjects from Banner-University Medical Center/University of Arizona dermatology clinics and University of California, Davis dermatology clinics (up to 20 subjects per site) who have dry skin will be enrolled in this study and randomized to receive the four moisturizers on four locations on their forearms.There will be a total of 3 study sessions: baseline, and approximately 1 and 2 weeks for follow up assessment. At each visit, dry skin severity will be evaluated by a trained observer using a validated Dry Skin Score, skin barrier biophysical properties (transepidermal water loss and hydration) will be measured, and digital photos of the test sites will be taken for image analysis.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date December 12, 2017
Est. primary completion date June 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Male and female, at least 18 years of age

2. Subject must receive a diagnosis of dry skin by a dermatologist.

3. Subject must be able to comprehend and read the English language.

Exclusion Criteria:

1. Subjects who do not fit the inclusion criteria.

2. Subjects unable to or unwilling to comply with the study procedures

3. Prior known allergy to white petrolatum, coconut oil, almond oil, or jojoba oil.

4. People who have used products containing white petrolatum, jojoba oil, coconut oil, or almond oil within the past week.

5. People with a known diagnosis of ichthyosis.

6. A subject who, in the opinion of the investigator, will be un-cooperative or unable to comply with study procedures.

7. Subject unable to speak or read the English language, since all consents and instructions will be provided in English.

8. Those that are prisoners or cognitively impaired

Study Design


Related Conditions & MeSH terms


Intervention

Other:
virgin coconut oil
One of the four locations (right proximal forearm, right distal forearm, left proximal forearm, left distal forearm) on the forearm will be selected to receive virgin coconut oil application twice daily for 2 weeks.
virgin jojoba oil
One of the four locations (right proximal forearm, right distal forearm, left proximal forearm, left distal forearm) on the forearm will be selected to receive virgin jojoba oil application twice daily for 2 weeks.
virgin almond oil
One of the four locations (right proximal forearm, right distal forearm, left proximal forearm, left distal forearm) on the forearm will be selected to receive virgin almond oil application twice daily for 2 weeks.
white petrolatum ointment
One of the four locations (right proximal forearm, right distal forearm, left proximal forearm, left distal forearm) on the forearm will be selected to receive white petrolatum ointment application twice daily for 2 weeks.

Locations

Country Name City State
United States University of California, Davis Sacramento California
United States University of Arizona, Banner-University Medical Center Tucson Arizona

Sponsors (2)

Lead Sponsor Collaborator
University of Arizona University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Skin barrier biophysical properties of xerosis Transepidermal water loss (TEWL) and stratum corneum hydration status will be measured using hand-held, noninvasive, skin barrier measuring devices (Tewameter and moistureMeter) 14 days
Primary The appearance of xerosis The clinical severity of xerosis of the 4 location will be graded by a trained observed using a previously validated Dry Skin Scale and by analysis of the digital photos. 14 days
See also
  Status Clinical Trial Phase
Completed NCT05046015 - Comparison Dry Foot Skin Between Diabetic and Non-diabetic Subjects and the Effects of Two Cosmetic Foot Care Products N/A
Completed NCT02216526 - Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents N/A
Completed NCT03824886 - Enhancing SKIN Health and Safety in Aged CARE N/A
Completed NCT02557698 - Effectiveness of Using an Oil Bath Additive N/A
Active, not recruiting NCT03815305 - Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2 Phase 4
Recruiting NCT05639933 - Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors Phase 2
Completed NCT04253704 - Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin Phase 1/Phase 2
Completed NCT06178367 - Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment Phase 3
Completed NCT04127513 - Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis Phase 3